These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 7760001)

  • 21. Interleukin-1 upregulates anaphylatoxin receptors on mononuclear cells.
    Takabayashi T; Shimizu S; Clark BD; Beinborn M; Burke JF; Gelfand JA
    Surgery; 2004 May; 135(5):544-54. PubMed ID: 15118592
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A recombinant hybrid anaphylatoxin with dual C3a/C5a activity.
    Bautsch W; Kretzschmar T; Stühmer T; Kola A; Emde M; Köhl J; Klos A; Bitter-Suermann D
    Biochem J; 1992 Nov; 288 ( Pt 1)(Pt 1):261-6. PubMed ID: 1445269
    [TBL] [Abstract][Full Text] [Related]  

  • 23. C5a, but not C3a, increases VEGF secretion in ARPE-19 human retinal pigment epithelial cells.
    Cortright DN; Meade R; Waters SM; Chenard BL; Krause JE
    Curr Eye Res; 2009 Jan; 34(1):57-61. PubMed ID: 19172471
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evidence that the receptor for C4a is distinct from the C3a receptor.
    Ames RS; Tornetta MA; Foley JJ; Hugli TE; Sarau HM
    Immunopharmacology; 1997 Dec; 38(1-2):87-92. PubMed ID: 9476119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of theophylline on human eosinophil functions: comparative study with neutrophil functions.
    Yasui K; Agematsu K; Shinozaki K; Hokibara S; Nagumo H; Yamada S; Kobayashi N; Komiyama A
    J Leukoc Biol; 2000 Aug; 68(2):194-200. PubMed ID: 10947063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C3a and C5a are chemotactic factors for human mesenchymal stem cells, which cause prolonged ERK1/2 phosphorylation.
    Schraufstatter IU; Discipio RG; Zhao M; Khaldoyanidi SK
    J Immunol; 2009 Mar; 182(6):3827-36. PubMed ID: 19265162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of C3a receptor expression on human leucocytes by the use of novel monoclonal antibodies.
    Zwirner J; Götze O; Begemann G; Kapp A; Kirchhoff K; Werfel T
    Immunology; 1999 May; 97(1):166-72. PubMed ID: 10447728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the binding of fluorescent C5a and C3a to human peripheral blood leukocytes.
    van Epps DE; Chenoweth DE
    J Immunol; 1984 Jun; 132(6):2862-7. PubMed ID: 6373920
    [TBL] [Abstract][Full Text] [Related]  

  • 29. C3a and C5a stimulate chemotaxis of human mast cells.
    Hartmann K; Henz BM; Krüger-Krasagakes S; Köhl J; Burger R; Guhl S; Haase I; Lippert U; Zuberbier T
    Blood; 1997 Apr; 89(8):2863-70. PubMed ID: 9108406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation by complement C3a and C5a anaphylatoxins of cytokine production in human umbilical vein endothelial cells.
    Monsinjon T; Gasque P; Chan P; Ischenko A; Brady JJ; Fontaine MC
    FASEB J; 2003 Jun; 17(9):1003-14. PubMed ID: 12773483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Modulation of C3a activity: internalization of the human C3a receptor and its inhibition by C5a.
    Settmacher B; Bock D; Saad H; Gärtner S; Rheinheimer C; Köhl J; Bautsch W; Klos A
    J Immunol; 1999 Jun; 162(12):7409-16. PubMed ID: 10358194
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Detection of C5a receptors on human eosinophils and inhibition of eosinophil effector functions by anti-C5a receptor (CD88) antibodies.
    Elsner J; Oppermann M; Kapp A
    Eur J Immunol; 1996 Jul; 26(7):1560-4. PubMed ID: 8766561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamics of a chemoattractant receptor in living neutrophils during chemotaxis.
    Servant G; Weiner OD; Neptune ER; Sedat JW; Bourne HR
    Mol Biol Cell; 1999 Apr; 10(4):1163-78. PubMed ID: 10198064
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Xenopus oocytes the human C3a and C5a receptors elicit a promiscuous response to the anaphylatoxins.
    Ames RS; Nuthulaganti P; Kumar C
    FEBS Lett; 1996 Oct; 395(2-3):157-9. PubMed ID: 8898085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of a receptor for C5a anaphylatoxin on human eosinophils.
    Gerard NP; Hodges MK; Drazen JM; Weller PF; Gerard C
    J Biol Chem; 1989 Jan; 264(3):1760-6. PubMed ID: 2912983
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Moderate inhibitory effect of interleukin-10 on human neutrophil and monocyte chemotaxis in vitro.
    Vicioso MA; Garaud JJ; Réglier-Poupet H; Lebeaut A; Gougerot-Pocidalo MA; Chollet-Martin S
    Eur Cytokine Netw; 1998 Sep; 9(3):247-53. PubMed ID: 9831173
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mechanism for substance P-induced activation of human neutrophils and eosinophils.
    Iwamoto I; Nakagawa N; Yamazaki H; Kimura A; Tomioka H; Yoshida S
    Regul Pept; 1993 Jul; 46(1-2):228-30. PubMed ID: 7692498
    [No Abstract]   [Full Text] [Related]  

  • 38. Studies on C3ahu binding to human eosinophils: characterization of binding.
    Goers JW; Glovsky MM; Hunkapiller MW; Farnsworth V; Richards JH
    Int Arch Allergy Appl Immunol; 1984; 74(2):147-51. PubMed ID: 6609131
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Actin polymerization in human eosinophils, unlike human neutrophils, depends on intracellular calcium mobilization.
    Elsner J; Dichmann S; Dobos GJ; Kapp A
    J Cell Physiol; 1996 Jun; 167(3):548-55. PubMed ID: 8655608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anaphylatoxins C5a and C3a induce nuclear factor kappaB activation in human peripheral blood monocytes.
    Pan ZK
    Biochim Biophys Acta; 1998 Nov; 1443(1-2):90-8. PubMed ID: 9838061
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.